COVID-19 Tetra Bio-Pharma gets 5th orphan drug status for CBD topical The company is expanding its strategy of obtaining rare drug designations for cannabis-based drugs during the pandemic Jared GnamApril 23, 2020
Medical and Pharmaceutical Cannabinol (CBN) the main ingredient in potential treatments for glaucoma and a rare skin disease InMed Pharmaceuticals has initiated a clinical trial for its epidermolysis bullosa treatment, after regulatory approval in December Nick LabaJanuary 20, 2020